Last reviewed · How we verify
Probiotic capsules
Probiotic capsules introduce beneficial live microorganisms into the gastrointestinal tract to restore and maintain healthy gut microbiota balance.
Probiotic capsules introduce beneficial live microorganisms into the gastrointestinal tract to restore and maintain healthy gut microbiota balance. Used for Gastrointestinal health maintenance, Antibiotic-associated diarrhea prevention or treatment, Irritable bowel syndrome symptom management.
At a glance
| Generic name | Probiotic capsules |
|---|---|
| Also known as | Lactobacillus reuteri capsules |
| Sponsor | Sahlgrenska University Hospital |
| Drug class | Probiotic |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | FDA-approved |
Mechanism of action
Probiotics are live bacteria and/or yeasts that colonize the intestinal tract and compete with pathogenic microorganisms for nutrients and adhesion sites. They produce short-chain fatty acids, bacteriocins, and other metabolites that support intestinal barrier function, enhance immune tolerance, and promote overall gastrointestinal health. By restoring eubiotic conditions, probiotics may reduce inflammation and improve digestive function.
Approved indications
- Gastrointestinal health maintenance
- Antibiotic-associated diarrhea prevention or treatment
- Irritable bowel syndrome symptom management
Common side effects
- Bloating
- Flatulence
- Mild gastrointestinal discomfort
Key clinical trials
- Effect of L. Reuteri LM1063 on Sleep Health Improvement (NA)
- Evaluation of the Ability of Lactobacillus Crispatus CRP21 to Reduce the Incidence of Recurrent Bacterial Vaginosis (NA)
- Probiotic (LGG) for Veterans With PTSD (PHASE2)
- Clinical Trial of Lactiplantibacillus Plantarum Dad-13 on Gut Microbiota Profile and Performance in Adolescent Athletes (NA)
- Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms (NA)
- Efficacy and Safety Study of BPR-101 Capsules in Combination With Metronidazole in BV Patients (PHASE2)
- A Study to Assess the Effect of the Bio-K+ Probiotic Capsules (VL-BK-02) in Adults With Functional Constipation (NA)
- Synbiotic to Attenuate Resorption of the Skeleton (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Probiotic capsules CI brief — competitive landscape report
- Probiotic capsules updates RSS · CI watch RSS
- Sahlgrenska University Hospital portfolio CI